If we adjoin that trend line, the support comes in at around today’s low only. But overall, the way it has come down from the higher levels, it looks like that the bears are having more dominance right now and the chances of going down looking higher than from here.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This